Published in Am J Nephrol on July 26, 2012
Dialysis dose and intradialytic hypotension: results from the HEMO study. Am J Nephrol (2013) 0.91
Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline. Am J Kidney Dis (2015) 0.76
Study protocol for a single-blind, placebo-controlled randomised trial of Tianjiu effects in patients with intradialytic hypotension. BMJ Open (2016) 0.75
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int (2004) 2.71
Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis (2008) 2.24
Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int (2006) 2.23
Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol (2007) 2.22
Effect of hyperosmolality on vasopressin secretion in intradialytic hypotension: a mechanistic study. Am J Kidney Dis (2008) 2.14
Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol (1996) 1.76
Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis (2006) 1.49
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol (2005) 1.37
Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol (2008) 1.36
Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol (2004) 1.31
Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: a 3-year prospective study. Nephron Clin Pract (2004) 1.30
Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis (2000) 1.22
Role of sodium in hemodialysis. Kidney Int Suppl (2000) 1.11
Role of osmolality in blood pressure stability after dialysis and ultrafiltration. Kidney Int (1980) 1.09
Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume. Nephron Clin Pract (2004) 1.06
Sodium ramping in hemodialysis: a study of beneficial and adverse effects. Am J Kidney Dis (1997) 1.04
Mannitol. West J Med (1979) 0.95
Sodium modeling ameliorates intradialytic and interdialytic symptoms in young hemodialysis patients. J Am Soc Nephrol (1993) 0.95
Model prediction of plasma volume change induced by hemodialysis. J Lab Clin Med (1984) 0.84
Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps. ASAIO Trans (1992) 0.83
Serum vasopressin response in patients with intradialytic hypotension: a pilot study. Clin J Am Soc Nephrol (2008) 0.82
Vasopressin secretion by hypertonic saline infusion during hemodialysis: effect of cardiopulmonary recirculation. Nephrol Dial Transplant (2011) 0.81
The value of sequential dialysis, mannitol and midodrine in managing children prone to dialysis failure. Pediatr Nephrol (2009) 0.81
Myocardial contractile function and intradialytic hypotension. Hemodial Int (2009) 0.80
Effects of high sodium dialysate during maintenance hemodialysis. Nephron (1985) 0.79
Mannitol infusion in regular haemodialysis treatment for chronic renal insufficiency. Scand J Urol Nephrol (1969) 0.78
Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci (2008) 2.98
Randomized controlled trial of calcitriol in severe sepsis. Am J Respir Crit Care Med (2014) 2.79
A rapid urine test for early detection of kidney injury. Kidney Int (2009) 2.50
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis (2013) 2.42
Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30
Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med (2011) 2.11
Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery. J Hosp Med (2014) 2.04
Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int (2009) 1.94
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Preoperative statin use and postoperative acute kidney injury. Am J Med (2012) 1.87
Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int (2012) 1.71
Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest (2015) 1.59
Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol (2013) 1.58
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken) (2011) 1.57
Phosphate balance in continuous venovenous hemofiltration. Am J Kidney Dis (2013) 1.48
Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists. JAMA Intern Med (2013) 1.46
Established and emerging markers of kidney function. Clin Chem (2012) 1.45
Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int (2013) 1.42
Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant (2009) 1.39
Performance and limitations of administrative data in the identification of AKI. Clin J Am Soc Nephrol (2014) 1.38
Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol (2013) 1.37
Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. J Vasc Surg (2006) 1.37
Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol Sci (2012) 1.24
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clin J Am Soc Nephrol (2012) 1.20
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J Am Coll Cardiol (2005) 1.16
A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med (2013) 1.14
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol (2012) 1.13
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.11
Saving the kidneys by sparing intravenous chloride? JAMA (2012) 1.07
Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury. Blood (2011) 1.07
Rosuvastatin for sepsis-associated ARDS. N Engl J Med (2014) 1.07
Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin Chem (2013) 1.04
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol (2010) 1.04
FGF-23 levels in patients with AKI and risk of adverse outcomes. Clin J Am Soc Nephrol (2012) 1.01
Dialysate sodium, serum sodium and mortality in maintenance hemodialysis. Nephrol Dial Transplant (2011) 0.98
Chronic on acute renal failure: long-term implications of severe acute kidney injury. JAMA (2009) 0.98
Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes. Clin Endocrinol (Oxf) (2013) 0.97
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia (2014) 0.97
Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol (2014) 0.92
Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury. Am J Med (2008) 0.91
Biomarkers in nephrology: Core Curriculum 2013. Am J Kidney Dis (2013) 0.91
Dialysis dose and intradialytic hypotension: results from the HEMO study. Am J Nephrol (2013) 0.91
Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury. Am J Pathol (2012) 0.88
Diuretics in acute kidney injury. Semin Nephrol (2011) 0.83
Optimal dialysate sodium-what is the evidence? Semin Dial (2014) 0.83
Acute phosphate nephropathy. Kidney Int (2008) 0.81
Peri-surgical statins lessen acute kidney injury. J Am Soc Nephrol (2011) 0.80
Can we rely on blood urea nitrogen as a biomarker to determine when to initiate dialysis? Clin J Am Soc Nephrol (2006) 0.79
Association of smoking with cardiovascular and infection-related morbidity and mortality in chronic hemodialysis. Clin J Am Soc Nephrol (2012) 0.79
Toward the promise of renal replacement therapy. J Am Soc Nephrol (2008) 0.78
Vitamin D metabolism and action in human marrow stromal cells: effects of chronic kidney disease. J Steroid Biochem Mol Biol (2012) 0.77
Dialysate sodium and the milieu intérieur. Clin J Am Soc Nephrol (2011) 0.76
Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation. JCI Insight (2017) 0.75
Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery. Clin J Am Soc Nephrol (2012) 0.75
Reply: active and native vitamin D in critical illness. Am J Respir Crit Care Med (2014) 0.75
The relevance of dietary sodium in hemodialysis. Nephrol Dial Transplant (2012) 0.75